Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 38RL9AE51Q |
Primary Target | |
---|---|
interferon α/β receptor 1 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lupus Erythematosus, Systemic | 4 | D008180 | ClinicalTrials |
Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Lupus Nephritis | 2 | D008181 | ClinicalTrials |
Scleroderma, Localized | 1 | D012594 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1326232-46-5 |
ChEMBL | CHEMBL2364653 |
FDA SRS | 38RL9AE51Q |
Guide to Pharmacology | 8258 |